These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 33295613)

  • 1. Value of the cell cycle arrest biomarkers in the diagnosis of pregnancy-related acute kidney injury.
    El Minshawy O; Khedr MHS; Youssuf AM; Abo Elela M; Kamel FMM; Keryakos HKH
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33295613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication.
    Bihorac A; Chawla LS; Shaw AD; Al-Khafaji A; Davison DL; Demuth GE; Fitzgerald R; Gong MN; Graham DD; Gunnerson K; Heung M; Jortani S; Kleerup E; Koyner JL; Krell K; Letourneau J; Lissauer M; Miner J; Nguyen HB; Ortega LM; Self WH; Sellman R; Shi J; Straseski J; Szalados JE; Wilber ST; Walker MG; Wilson J; Wunderink R; Zimmerman J; Kellum JA
    Am J Respir Crit Care Med; 2014 Apr; 189(8):932-9. PubMed ID: 24559465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraoperative prediction of cardiac surgery-associated acute kidney injury using urinary biomarkers of cell cycle arrest.
    Cummings JJ; Shaw AD; Shi J; Lopez MG; O'Neal JB; Billings FT
    J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1545-1553.e5. PubMed ID: 30389130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early prediction of acute kidney injury after transapical and transaortic aortic valve implantation with urinary G1 cell cycle arrest biomarkers.
    Dusse F; Edayadiyil-Dudásova M; Thielmann M; Wendt D; Kahlert P; Demircioglu E; Jakob H; Schaefer ST; Pilarczyk K
    BMC Anesthesiol; 2016 Sep; 16():76. PubMed ID: 27609347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serial Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 and the Prognosis for Acute Kidney Injury over the Course of Critical Illness.
    McCullough PA; Ostermann M; Forni LG; Bihorac A; Koyner JL; Chawla LS; Shi J; Kampf JP; McPherson P; Kellum JA;
    Cardiorenal Med; 2019; 9(6):358-369. PubMed ID: 31618746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery.
    Meersch M; Schmidt C; Van Aken H; Martens S; Rossaint J; Singbartl K; Görlich D; Kellum JA; Zarbock A
    PLoS One; 2014; 9(3):e93460. PubMed ID: 24675717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current understanding and future directions in the application of TIMP-2 and IGFBP7 in AKI clinical practice.
    Fan W; Ankawi G; Zhang J; Digvijay K; Giavarina D; Yin Y; Ronco C
    Clin Chem Lab Med; 2019 Apr; 57(5):567-576. PubMed ID: 30179848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary biomarkers TIMP-2 and IGFBP7 early predict acute kidney injury after major surgery.
    Gocze I; Koch M; Renner P; Zeman F; Graf BM; Dahlke MH; Nerlich M; Schlitt HJ; Kellum JA; Bein T
    PLoS One; 2015; 10(3):e0120863. PubMed ID: 25798585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) • Insulin-Like Growth Factor-Binding Protein 7 (IGFBP7) Predicts Adverse Outcome in Pediatric Acute Kidney Injury.
    Westhoff JH; Tönshoff B; Waldherr S; Pöschl J; Teufel U; Westhoff TH; Fichtner A
    PLoS One; 2015; 10(11):e0143628. PubMed ID: 26606754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue inhibitor metalloproteinase-2 (TIMP-2) • IGF-binding protein-7 (IGFBP7) levels are associated with adverse outcomes in patients in the intensive care unit with acute kidney injury.
    Xie Y; Ankawi G; Yang B; Garzotto F; Passannante A; Breglia A; Digvijay K; Ferrari F; Brendolan A; Raffaele B; Giavarina D; Gregori D; Ronco C
    Kidney Int; 2019 Jun; 95(6):1486-1493. PubMed ID: 30982674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The urine biomarkers TIMP2 and IGFBP7 can identify patients who will experience severe acute kidney injury following a cardiac arrest: A prospective multicentre study.
    Titeca-Beauport D; Daubin D; Chelly J; Zerbib Y; Brault C; Diouf M; Slama M; Vinsonneau C; Klouche K; Maizel J
    Resuscitation; 2019 Aug; 141():104-110. PubMed ID: 31216431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of acute kidney injury and the role of urinary [TIMP-2]·[IGFBP7]: a prospective cohort study in critically ill obstetric patients.
    Tyagi A; Luthra A; Kumar M; Das S
    Int J Obstet Anesth; 2018 Nov; 36():77-84. PubMed ID: 30245258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of cell cycle arrest biomarkers in patients at high risk for acute kidney injury: A systematic review and meta-analysis.
    Jia HM; Huang LF; Zheng Y; Li WX
    Nephrology (Carlton); 2017 Nov; 22(11):831-837. PubMed ID: 28646585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TIMP-2/IGFBP7 predicts acute kidney injury in out-of-hospital cardiac arrest survivors.
    Adler C; Heller T; Schregel F; Hagmann H; Hellmich M; Adler J; Reuter H
    Crit Care; 2018 May; 22(1):126. PubMed ID: 29751827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urine cell cycle arrest biomarkers distinguish poorly between transient and persistent AKI in early septic shock: a prospective, multicenter study.
    Titeca-Beauport D; Daubin D; Van Vong L; Belliard G; Bruel C; Alaya S; Chaoui K; Andrieu M; Rouquette-Vincenti I; Godde F; Pascal M; Diouf M; Vinsonneau C; Klouche K; Maizel J
    Crit Care; 2020 Jun; 24(1):280. PubMed ID: 32487237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7 as biomarkers of patients with established acute kidney injury.
    Cho WY; Lim SY; Yang JH; Oh SW; Kim MG; Jo SK
    Korean J Intern Med; 2020 May; 35(3):662-671. PubMed ID: 31856559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin nephrotoxicity is not detected by urinary cell-cycle arrest biomarkers in lung cancer patients.
    Toprak Z; Cebeci E; Helvaci SA; Toprak ID; Kutlu Y; Sakin A; Tukek T
    Int Urol Nephrol; 2017 Jun; 49(6):1041-1047. PubMed ID: 28255639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of urinary cell cycle arrest biomarkers for all cause-acute kidney injury: a meta-analysis.
    Huang F; Zeng Y; Lv L; Chen Y; Yan Y; Luo L; Pan R; Jiang J; Wei X
    Sci Rep; 2023 Apr; 13(1):6037. PubMed ID: 37055509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell Cycle Biomarkers and Soluble Urokinase-Type Plasminogen Activator Receptor for the Prediction of Sepsis-Induced Acute Kidney Injury Requiring Renal Replacement Therapy: A Prospective, Exploratory Study.
    Nusshag C; Rupp C; Schmitt F; Krautkrämer E; Speer C; Kälble F; Tamulyte S; Bruckner T; Zeier M; Reiser J; Weigand MA; Uhle F; Merle U; Morath C; Brenner T
    Crit Care Med; 2019 Dec; 47(12):e999-e1007. PubMed ID: 31584458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reference intervals of urinary acute kidney injury (AKI) markers [IGFBP7]∙[TIMP2] in apparently healthy subjects and chronic comorbid subjects without AKI.
    Chindarkar NS; Chawla LS; Straseski JA; Jortani SA; Uettwiller-Geiger D; Orr RR; Kellum JA; Fitzgerald RL
    Clin Chim Acta; 2016 Jan; 452():32-7. PubMed ID: 26522657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.